Crown Laboratories and Revance Therapeutics Announce Expiration of Tender Offer
Press Releases
February 5, 2025

Crown Laboratories and Revance Therapeutics Announce Expiration of Tender Offer

JOHNSON CITY, Tenn. and NASHVILLE, Tenn., Feb. 5, 2025 /PRNewswire/ -- Crown Laboratories, Inc. ("Crown") and Revance Therapeutics, Inc. (NASDAQ: RVNC) ("Revance"), today announced that the tender offer to purchase

bradford

The Bradford Era

Local & Social